Russian Direct Investment Fund, Stelis Biopharma join hands to supply 200M Sputnik V vax doses
Moscow | The Russian Direct Investment Fund (RDIF) and Indian pharmaceutical firm Stelis Biopharma on Friday announced its partnership to produce...
Moscow | The Russian Direct Investment Fund (RDIF) and Indian pharmaceutical firm Stelis Biopharma on Friday announced its partnership to produce...